FAIR VALUE MEASUREMENTS (Tables)
|
9 Months Ended |
Jun. 30, 2026 |
|---|
| FAIR VALUE MEASUREMENTS [Abstract] |
|
| Assets and Liabilities Measured at Fair Value on Recurring Basis |
The following table presents the Company’s assets that are measured at fair value on a recurring basis based on the three-level valuation hierarchy:
| | | | | | | | | | | | | | | | | |
|
June 30, 2026
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Total
|
|
|
Investment in marketable securities at fair value
|
| $ |
427 | |
| $ |
- | |
| $ |
- | |
| $ |
427 | |
|
Restricted investments
|
| |
250 | |
| |
- | |
| |
- | |
| |
250 | |
|
Total Assets
|
| $ |
677 | |
| $ |
- | |
| $ |
- | |
| $ |
677 | |
| | | | | | | | | | | | | | | | | |
|
September 30, 2025
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Total
|
|
|
Investment in Rubicon at fair value
|
| $ |
4,631 | |
| $ |
- | |
| $ |
- | |
| $ |
4,631 | |
|
Investment in marketable securities at fair value
|
| |
33 | |
| |
- | |
| |
- | |
| |
33 | |
|
Restricted investments
|
| |
250 | |
| |
- | |
| |
- | |
| |
250 | |
|
Total Assets
|
| $ |
4,914 | |
| $ |
- | |
| $ |
- | |
| $ |
4,914 | |
The following table presents the Company’s liabilities that are measured at fair value on a recurring basis based on the three-level valuation hierarchy:
| | | | | | | | | | | | | | | | | |
|
June 30, 2026
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Total
|
|
|
Contingent earnout
|
| $ |
64 | |
| $ |
- | |
| $ |
1,471 | |
| $ |
1,535 | |
|
Mandatorily redeemable noncontrolling interest
|
| |
- | |
| |
- | |
| |
2,722 | |
| |
2,722 | |
|
Total Liabilities
|
| $ |
64 | |
| $ |
- | |
| $ |
4,193 | |
| $ |
4,257 | |
| | | | | | | | | | | | | | | | | |
|
September 30, 2025
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Total
|
|
|
Contingent earnout
|
| $ |
1,143 | |
| $ |
- | |
| $ |
1,504 | |
| $ |
2,647 | |
|
Mandatorily redeemable noncontrolling interest
|
| |
- | |
| |
- | |
| |
4,161 | |
| |
4,161 | |
|
Total Liabilities
|
| $ |
1,143 | |
| $ |
- | |
| $ |
5,665 | |
| $ |
6,808 | |
|
| Marketable Securities and Restricted Investments |
The following table sets forth a summary of the changes in the investment in marketable securities and restricted investments during the three and nine months ended June 30, 2026 and 2025:
| |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
| Three Months Ended
June 30, | |
| Nine Months Ended
June 30, |
|
| |
|
2026
|
|
|
2025
|
|
|
2026
|
|
|
2025
|
|
|
Balance, beginning of period
|
| $ |
513 |
|
| $ |
2,760 |
|
| $ |
4,914 |
|
| $ |
1,824 |
|
| Acquisition of controlling financial interest of Rubicon |
| |
- |
|
| |
- |
|
| |
(4,631 |
) |
| |
- |
|
|
Unrealized gain (loss)
|
| |
(35 |
) |
| |
(80 |
) |
| |
93 |
|
| |
793 |
|
|
Purchase of securities (net of sales)
|
| |
199 |
|
| |
79 |
|
| |
301 |
|
| |
142 |
|
|
Balance, end of period
|
| $ |
677 |
|
| $ |
2,759 |
|
| $ |
677 |
|
| $ |
2,759 |
|
|
| Changes in Fair Value of Investment in Rubicon Measured at Fair Value on Recurring Basis Utilizing Level 1 Assumptions |
The following table sets forth a summary of the changes in the fair value of the Company’s investment in Rubicon, which was measured at fair value on a recurring basis prior to October 14, 2025, utilizing Level 1 assumptions in its valuation:
| |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| Three Months Ended
June 30, | |
| Nine Months Ended
June 30, |
|
| |
|
2026
|
|
|
2025
|
|
|
2026
|
|
|
2025
|
|
|
Balance, beginning of period
|
| $ |
- |
|
| $ |
2,415 |
|
| $ |
4,631 |
|
| $ |
1,518 |
|
|
Fair value adjustment to Rubicon investment
|
| |
- |
|
| |
(88 |
) |
| |
(4,631 |
) |
| |
809 |
|
|
Balance, end of period
|
| $ |
- |
|
| $ |
2,327 |
|
| $ |
- |
|
| $ |
2,327 |
|
|
| Changes in Fair Value of Contingent Earnout Liabilities Measured at Fair Value on Recurring Basis Utilizing Level 1 and Level 3 Assumptions |
The following table sets forth a summary of the changes in the fair value of the Company’s contingent earnout liabilities for the three and nine months ended June 30, 2026 and 2025, which are measured at fair value on a recurring basis utilizing Level 1 and Level 3 assumptions in their valuation:
| |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| Three Months Ended
June 30, | |
| Nine Months Ended
June 30, |
|
| |
|
2026
|
|
|
2025
|
|
|
2026
|
|
|
2025
|
|
|
Balance, beginning of period
|
| $ |
94 |
|
| $ |
1,332 |
|
| $ |
2,647 |
|
| $ |
2,350 |
|
|
Fair value of contingent consideration recorded in connection with business combinations and asset purchases
|
| |
1,441 |
|
| |
30 |
|
| |
1,441 |
|
| |
90 |
|
|
Earnout payment
|
| |
- |
|
| |
- |
|
| |
(2,553 |
) |
| |
(1,078 |
) |
|
Change in earnout calculation
|
| |
- |
|
| |
100 |
|
| |
- |
|
| |
100 |
|
|
Balance, end of period
|
| $ |
1,535 |
|
| $ |
1,462 |
|
| $ |
1,535 |
|
| $ |
1,462 |
|
|